✦ LIBER ✦

P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder

✍ Scribed by M. Dragheim; H. Loft; I. Florea; J.P. Boulenger

Book ID: 118598347
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 75 KB
Volume: 21
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(11)70638-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.040 A randomised, double-blind, pl

P.2.c.040 A randomised, double-blind, placebo-controlled, active-referenced study of Lu AA21004 in patients with major depression

✍ F. Artigas; M. Dragheim; H. Loft; V. Perez; E. Álvarez 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 204 KB

P.2.c.015 A randomised, double-blind, pl

P.2.c.015 A randomised, double-blind, placebo-controlled, active-referenced study of the multimodal antidepressant Lu AA21004 in the treatment of elderly depressed patients

✍ C. Katona; T. Hansen; C.K. Olsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A double-blind dose-finding study of rol

A double-blind dose-finding study of rolipram in patients with major depressive disorder

✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

P.2.c.026 Superior antidepressant effica

P.2.c.026 Superior antidepressant efficacy of agomelatine vs fluoxetine in severe major depressive disorder patients: a randomised, double-blind study

✍ A. Hale; R. Corral; O. Mencacci; J. Saiz Ruiz; C. Albarran Severo; V. Gentil 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 196 KB

P.2.c.025 Long-term treatment with agome

P.2.c.025 Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months

✍ G.M. Goodwin; F. Rouillon; R. Emsley 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

P.2.c.038 Long-term efficacy of agomelat

P.2.c.038 Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder

✍ G.M. Goodwin; F. Rouillon; R. Emsley 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB